Practical Guidance for Building and Sustaining a Telestroke
Network
|
|
Business Model StrategiesWebinar One in a three-part series |
|
Original Event: Nov. 15, 2011
Estimated Time to Complete: 1 Hour Accreditation for this program has expired. |
|
This activity is jointly sponsored by Medical Education Resources and National Stroke Association.
Agenda
Business Model Strategies will
address:
- Evidence of efficacy in using telemedicine in acute stroke
- Initial funding options
- Reimbursement and program economics
- Ensuring sustainability
Learning Objectives
Through participation in this activity, participants should be better able to:
- Summarize the evidence that supports the reliability of telemedicine for diagnosis and efficacy in acute stroke treatment
- Identify strategies for funding the development of a telestroke network
- Discuss issues with respect to economic sustainability, cost effectiveness and the status of reimbursement for telestroke
- Discuss key components to maintaining the logistical and/or operational sustainability of a telestroke network
Target Audience
This series is designed for stroke center coordinators, medical directors, hospital administrators, neurologists and emergency medicine physicians. The audience may also include other stroke team members.
Faculty
| Bart M. Demaerschalk, MD, MSc, FRCP Professor of Neurology Mayo Clinic Hospital Scottsdale, AZ |
Christopher V. Fanale, MD Stroke Medical Director Swedish Medical Center Englewood, CO |
Program Materials
The enduring webinar is designed for
individual viewing. The posttest and evaluation are electronic and can only be completed by an individual after watching the program. There are no fees for participating in this activity.
Disclosure of Conflicts of Interest
MER ensures balance, independence, objectivity and scientific rigor in all our
educational programs. In accordance with this policy, MER identifies conflicts
of interest with its instructors, content managers and other individuals who
are in a position to control the content of an activity. Conflicts are resolved
by MER to ensure that all scientific research referred to, reported or used in
a CME activity conforms to the generally accepted standards of experimental
design, data collection and analysis. MER is committed to providing its
learners with high-quality CME activities that promote improvements or quality
in healthcare and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
| Name of Faculty | Report Financial Relationship | |
| Bart M. Demaerschalk, MD, MSc, FRCP | Investigator: National Stroke Association sponsored study on telestroke funded by Genentech, Inc. | |
| Christopher V. Fanale, MD | Speakers Bureau: Genentech, Inc.; Investigator: National Stroke
Association sponsored study on telestroke funded by Genentech, Inc. |
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
| Name of Content Manager | Report Financial Relationship | |
| Denise Henasey | No financial relationships to disclose | |
| Lori Conwell, CCMEP | No financial relationships to disclose |
|
System requirements:
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista
or newer. |
To view MER’s Privacy Policy: http://www.mer.org/privacy_policy
Non accredited On-demand Webinars
Webinar One: Business Model Strategies
|
|
Telestroke Network Fundamentals
|
|
Overcoming Challenges
|
The Practical Guidance for Building and Sustaining a Telestroke Webinar Series is brought to you by an educational grant from Genentech, Inc.

